Compound Detail
CHEMBL3137331
DEFACTINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1
Basic Information
| ChEMBL ID | CHEMBL3137331 |
| Name | DEFACTINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | FWLMVFUGMHIOAA-UHFFFAOYSA-N |
67
Targets
97
Activities
3
Assay Types
2
PK Parameters
20
Publications
3
Known Names
13
Indications
2
Mechanisms
Molecular Properties
510.5
MW (Da)
2.40
ALogP
9
HBA
3
HBD
142.1
PSA (Ų)
0.42
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Focal adhesion kinase 1 inhibitor | INHIBITOR | Focal adhesion kinase 1 | ✓ | ✓ |
| Protein tyrosine kinase 2 beta inhibitor | INHIBITOR | Protein-tyrosine kinase 2-beta | ✓ | ✓ |
Indications
Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Pancreatic Ductal Colorectal Neoplasms Genital Neoplasms, Female Lung Neoplasms Mesothelioma Pancreatic Neoplasms Thyroid Neoplasms Carcinoma, Endometrioid Melanoma Neoplasms Glioblastoma
Activity Summary
IC50 49 meas. best 9.7
Kd 41 meas. best 9.3
Ki 7 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Protein-tyrosine kinase 2-beta CHEMBL5469 | IC50 | 9.7 | 8.82 | 0.2 | 3 |
| Focal adhesion kinase 1 CHEMBL2695 | IC50 | 9.7 | 8.9508 | 0.2 | 12 |
| Focal adhesion kinase 1 CHEMBL2695 | Kd | 9.3 | 9.3 | 0.5 | 1 |
| Unchecked CHEMBL612545 | IC50 | 9.22 | 9.22 | 0.6 | 1 |
| Focal adhesion kinase 1 CHEMBL2695 | Ki | 9.0 | 9.0 | 1.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 8.72 | 6.8367 | 1.9 | 3 |
| Cyclin-dependent kinase-like 5 CHEMBL1163112 | Kd | 7.8 | 7.8 | 16.0 | 1 |
| Protein-tyrosine kinase 2-beta CHEMBL5469 | Kd | 7.62 | 6.995 | 24.0 | 2 |
| High affinity nerve growth factor receptor CHEMBL2815 | IC50 | 7.58 | 7.36 | 26.6 | 3 |
| Adenosine receptor A3 CHEMBL256 | Ki | 7.57 | 7.57 | 27.0 | 2 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 7.55 | 7.55 | 28.2 | 1 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | IC50 | 7.26 | 7.26 | 54.9 | 1 |
| NT-3 growth factor receptor CHEMBL5608 | IC50 | 7.24 | 7.24 | 57.8 | 1 |
| Mitogen-activated protein kinase kinase kinase 9 CHEMBL2872 | IC50 | 7.12 | 7.12 | 75.3 | 2 |
| Tyrosine-protein kinase JAK3 CHEMBL2148 | IC50 | 6.94 | 6.94 | 114.9 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 CHEMBL3553 | IC50 | 6.89 | 6.89 | 129.0 | 1 |
| Aurora kinase A CHEMBL4722 | IC50 | 6.87 | 6.87 | 135.0 | 1 |
| Dual specificity protein kinase CLK1 CHEMBL4224 | IC50 | 6.6 | 6.6 | 250.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 6.56 | 6.56 | 273.2 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | Kd | 6.47 | 6.47 | 340.0 | 1 |
| Cyclin-dependent kinase 2/cyclin A CHEMBL2094128 | IC50 | 6.46 | 6.46 | 344.0 | 1 |
| Adenosine receptor A2a CHEMBL251 | Ki | 6.43 | 6.43 | 370.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | IC50 | 6.38 | 6.38 | 416.0 | 1 |
| Serine/threonine-protein kinase MARK1 CHEMBL5940 | IC50 | 6.35 | 6.35 | 448.0 | 1 |
| NUAK family SNF1-like kinase 2 CHEMBL5698 | Kd | 6.34 | 6.34 | 454.0 | 1 |
| Aurora kinase A CHEMBL4722 | Kd | 6.21 | 6.21 | 622.0 | 1 |
| Protein-tyrosine kinase 2-beta CHEMBL5469 | Ki | 6.2 | 6.2 | 630.0 | 1 |
| Cyclin-dependent kinase 12 CHEMBL3559692 | Kd | 6.14 | 6.14 | 730.0 | 1 |
| Maternal embryonic leucine zipper kinase CHEMBL4578 | Kd | 6.05 | 6.05 | 897.0 | 1 |
| Serine/threonine-protein kinase 16 CHEMBL3938 | Kd | 6.05 | 6.05 | 893.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 11 CHEMBL2708 | Kd | 6.04 | 6.04 | 902.0 | 1 |
| High affinity nerve growth factor receptor CHEMBL2815 | Kd | 6.04 | 6.04 | 918.0 | 1 |
| Tyrosine-protein kinase Lyn CHEMBL3905 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Casein kinase II subunit alpha' CHEMBL4070 | Kd | 5.92 | 5.92 | 1201.0 | 1 |
| Tyrosine-protein kinase Fer CHEMBL3982 | Kd | 5.88 | 5.88 | 1303.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Kd | 5.88 | 5.88 | 1322.0 | 1 |
| Cyclin-dependent kinase 5 CHEMBL4036 | Kd | 5.85 | 5.85 | 1414.0 | 1 |
| Aurora kinase B CHEMBL2185 | Kd | 5.83 | 5.83 | 1464.0 | 1 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | Kd | 5.83 | 5.83 | 1462.0 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 5.79 | 5.79 | 1640.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | Kd | 5.78 | 5.78 | 1656.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | Kd | 5.76 | 5.76 | 1744.0 | 1 |
| Cyclin-dependent kinase 9 CHEMBL3116 | Kd | 5.75 | 5.75 | 1790.0 | 1 |
| Cyclin-dependent kinase 1 CHEMBL308 | Kd | 5.7 | 5.7 | 2014.0 | 1 |
| General transcription and DNA repair factor IIH helicase subunit XPD CHEMBL4105743 | Kd | 5.65 | 5.65 | 2259.0 | 1 |
| Serine/threonine-protein kinase 4 CHEMBL4598 | Kd | 5.61 | 5.61 | 2450.0 | 1 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | IC50 | 5.6 | 5.6 | 2500.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 5.58 | 5.58 | 2650.0 | 1 |
| Serine/threonine-protein kinase MARK2 CHEMBL3831 | Kd | 5.58 | 5.58 | 2601.0 | 1 |
| Wee1-like protein kinase CHEMBL5491 | Kd | 5.58 | 5.58 | 2604.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 0.09 | hr | Homo sapiens |
| T1/2 | 0.02167 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | U2OS | 523 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 522 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 521 |
| 33497606 | 10.1016/j.chembiol.2021.01.003 | Unchecked | 27 |
| - | 10.6019/CHEMBL4507299 | Tyrosine-protein kinase ABL1 | 17 |
| - | 10.6019/CHEMBL5724696 | U2OS | 16 |
| - | 10.6019/CHEMBL4507299 | Epidermal growth factor receptor | 13 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL4507299 | Receptor-type tyrosine-protein kinase FLT3 | 11 |
| - | 10.6019/CHEMBL4507299 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| - | 10.6019/CHEMBL4507299 | Mast/stem cell growth factor receptor Kit | 9 |
| 34091209 | 10.1016/j.ejmech.2021.113573 | Unchecked | 7 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| 33497606 | 10.1016/j.chembiol.2021.01.003 | Protein-tyrosine kinase 2-beta | 6 |
| 33488961 | 10.1021/acsmedchemlett.0c00338 | Focal adhesion kinase 1 | 6 |
| - | 10.1158/2159-8290.CD-23-0050 | Colon cancer organoid | 5 |
| - | 10.6019/CHEMBL5212743 | Receptor-type tyrosine-protein kinase FLT3 | 5 |
| - | 10.6019/CHEMBL4507299 | Hepatocyte growth factor receptor | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
Data from ChEMBL 36 via Core Engine